A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

The vaccine was previously approved in the US to prevent LRTD related to RSV infection in adults 60 years or older and ...

Respiratory syncytial virus, the leading cause of infant hospitalization in the country, is peaking later and lasting longer ...

In outpatient care, RSV infections in children younger than 2 years present with distinct clinical features and greater ...

Respiratory syncytial virus, a common illness that can resemble a cold, is still sending infants to the hospital at higher ...

The respiratory illness RSV is still going strong in Chicago – an unusually late showing for the virus, which can strike ...

The Washington state Department of Health (DOH) has extended the availability of respiratory syncytial virus (RSV) immunizations for infants through April 30 as disease activity remains ...

Dr. Scott Lindquist with the Washington Department of Health joins the FOX Local Live Desk to talk more about the state's ...

The US regulator has cleared its Arexvy RSV shot for adults in that age group who are at increased ​risk of lower respiratory ...

Some respiratory viruses, especially RSV, are seeing a late winter to early spring surge in Wisconsin, public health experts say.

A respiratory virus without a specific treatment or vaccine is surging in several states across the U.S. Here's what we know ...

It’s a major cause of respiratory illness in all age groups, but young and old are at greatest risk.